Bioartificial liver treatment in rats with fulminant hepatic failure: Effect on DNA-binding activity of liver-enriched and growth-associated transcription factors

Journal of Surgical Research

Volumn 85, Issue 2, 1999, Pages 243-250

  Suh, Kyung Suk ^a   Lilja, Helene ^a   Kamohara, Yukio ^a   Eguchi, Susumu ^a   Arkadopoulos, Nikolaos ^a   Neuman, Toomas ^a   Demetriou, Achilles A ^a   Rozga, Jacek ^a  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Artificial liver; Hepatocyte; Hepatocyte growth factor; Liver failure; Transcription factors; Transforming growth factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SCATTER FACTOR; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; ARTIFICIAL ORGAN; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE EXPRESSION; LIVER CELL; LIVER FAILURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; TISSUE SPECIFICITY;

EID: 0344069534     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5669     Document Type: Article

References (27)

1. Eguchi S., Kamlot A., Ljubimova J., Hewitt W. R., Lebow L. T., Demetriou A. A., Rozga J. Fulminant hepatic failure in rats: Survival and effect on blood chemistry and liver regeneration. Hepatology. 24:1996;1452.
2. Eguchi S., Lilja H., Hewitt W. R., Middleton Y., Demetriou A. A., Rozga J. Loss and recovery of liver regeneration in rats with fulminant hepatic failure. J. Surg. Res. 72:1997;112.
3. Higgins G. M., Anderson R. M. Restoration of the liver of the white rat following partial surgical removal. AMA Arch. Pathol. 12:1931;186.
4. Rozga J., Jeppsson B., Bengmark S. Portal branch ligation in the rat: Reevaluation of a model. Am. J. Pathol. 125:1986;300.
5. Rozga J., Holzman M., Fujioka H., Morsiani E., Moscioni A. D., Demetriou A. A. Repeated intraportal hepatocyte transplantation in rats. Cell Transplant. 4:1994;237.
6. Rozga J., Williams R. F., Moscioni A. D., Giorgio T., Ro M. S., Neuzil D., Hakim R., Demetriou A. A. Development of a bioartificial liver support system. Hepatology. 17:1993;258.
7. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
8. Trey C. The fulminant hepatic failure surveillance study: Brief review of the effects of presumed etiology and age of survival. Can. Med. Assoc. J. 106:1992;522.
9. Ascher N., Lake J. R., Emond J. C., Roberts J. P. Liver transplantation for fulminant hepatic failure. Arch. Surg. 128:1993;677.
10. Bismuth H., Samuel D., Castaing D., Adam R., Saliba F., Johan M., Azoulay D. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann. Surg. 222:1995;109.
11. Pauwels A., Mostefa-Kara N., Florent C., Levy V. G. Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J. Hepatol. 17:1993;124.
12. Michalopoulos G. K., DeFrances M. C. Liver regeneration. Science. 276:1997;60.
13. Gomez-Lechon M. J., Castelli J., Guillen I., O'Connor E., Nakamura T., Fabra R., Trullenque R. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology. 21:1995;1248.
14. Tsubouchi H., Hirono S., Gohda E., Nakayama H., Takahashi K., Sakiyama O., Miyazaki H., Sugihara J., Tomita E., Muto Y., Daikuhara Y., Hashimoto S. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology. 9:1989;875.
15. Tsubouchi H., Niitani Y., Hirono S., Nakayama H., Gohda E., Arakaki N., Sakiyama O., Takahashi K., Kimoto M., Kawakami S., Setoguchi M., Tachikawa T., Shin S., Arima T., Daikuhara Y. Levels of human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 13:1991;1.
16. Shiota G., Okano J-I., Kawasaki H., Kawamoto T., Nakamura T. Serum hepatocyte growth factor levels in liver disease: Clinical implications. Hepatology. 21:1995;106.
17. Zieve L., Dozeman R. Effect of hepatic failure toxins on regenerative enzymes in the liver after injury with galactosamine in the rat. J. Lab. Clin. Med. 113:1989;463.
18. Hughes R. D., Yamada H., Gove C. D., Williams R. Inhibitors of hepatic DNA synthesis in fulminant hepatic failure. Dig. Dis. Sci. 36:1991;816.
19. Gove C. D., Hughes R. D., Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat livers by serum from patients with fulminant hepatic failure. Br. J. Exp. Pathol. 63:1982;547.
20. Wolf H. K., Michalopoulos G. K. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: A study of proliferating cell nuclear antigen expression. Hepatology. 15:1992;707.
21. Hanau C., Munoz S. J., Rubin R. Histopathological heterogeneity in fulminant hepatic failure. Hepatology. 21:1995;345.
22. Haber B., Maji L., Cressman D., Taub R. Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: Attainment and maintenance of the differentiated state during rapid proliferation. Hepatology. 22:1995;906.
23. Fausto N. Liver regeneration. Arias I. M., Jakoby W. B., Popper H. The Liver: Biology and Pathobiology. 1994;1058-1086 Raven Press, New York.
24. Westwick J. K., Weitzel C., Leffert H. L., Brenner D. A. Activation of Jun kinase is an early event in hepatic regeneration. J. Clin. Invest. 95:1995;803.
25. Cressman D. E., Greenbaum L. E., Haber B. A., Taub R. Rapid activation of PHF/NFκB in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269:1994;30429.
26. 3. Cancer Res. 22:1962;842.
27. Weinbren K., Taghizadeh A. The mitotic response after subtotal hepatectomy in the rat. Br. J. Exp. Pathol. 46:1964;413.